Targeted cryptosporidium biocides
US8394379B2 · kind B2 · utility
10Cited by
31References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 13, 2010 |
| Grant date | Mar 12, 2013 |
| Priority date | — |
| Expiry date | Oct 24, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/01
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to fusion proteins comprising a microorganism targeting molecule (e.g., immunoglobulin) and a biocide. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in diverse fields.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.